<p><img src="https://static4.businessinsider.com/image/6026eae8b3c2a800183ccb67-2400/spacex-starship-sn8-serial-number-8-boca-chica-beach-launch-pad-site-south-texas-SN8_20201110.jpg" border="0" alt="spacex starship sn8 serial number 8 boca chica beach launch pad site south texas SN8_20201110" data-mce-source="SpaceX" data-mce-caption="Starship serial no. 8, or SN8a rocket ship prototypesits at SpaceX's launch site in Boca Chica, Texas, on November 10, 2020." data-link="https://www.spacex.com/"></p><p></p><bi-shortcode id="summary-shortcode" data-type="summary-shortcode" class="mceNonEditable" contenteditable="false">Summary List Placement</bi-shortcode><p>The GameStop short squeeze and stock bonanza might have felt like a once-a-decade or once-in-a-lifetime event, but Goldman Sachs says it could happen again, and soon.</p><p>Even if there were many ways the social media-fueled frenzy in GameStop and AMC Networks and Bed Bath & Beyond was unique, many of its most notable ingredients are still there, according to Goldman Sachs. Chief among them are these two: There are a lot of big short bets on the market, and retail investors still have a ton of money.</p><p>While short bets against the average stock are low and hedge funds are dumping exposure, Goldman Chief US Equity Strategist David Kostin says there are still huge bets against specific stocksincluding GameStop and its recent short-squeeze peers.</p><p>"In the last three months, a basket containing the 50 Russell 3000 stocks with market caps above $1 billion and the largest short interest as a share of float has rallied by 98%," Kostin wrote in a research note published January 29.</p><p>He says that's unmatched in any other period. And while shorts against the average Russell 3000 stock are smallKostin says the average short interest as a percentage of the total share float is only 3%the heavily-shorted stocks can still blow up, and it would cause hedge funds just as much pain as it did in January. </p><p>"In recent years elevated crowding, low turnover, and high concentration have been consistent patterns, boosting the risk that one fund's unwind could snowball through the market," he wrote.</p><p>Meanwhile, Kostin says retail investors have a ton of money they could invest, in news the members of r/Wallstreetbets might be happy to hear.</p><p>"More than 50% of the $5 trillion in money market mutual funds is owned by households and is $1 trillion greater than before the pandemic," he wrote. "Regulatory actions, broker risk limits, or unexpected losses could all dampen the activity ... But otherwise, an abundance of US household cash should continue to fuel the trading boom."</p><p>Now that everyone is aware of the hidden potential in heavily shorted stocks, Kostin is identifying the <a href="https://www.businessinsider.com/stock-market-biggest-increase-in-short-interest-gamestop-reddit-goldman-2021-2">biggest short interest targets</a> on the market.</p><p>The 40 stocks listed here had the largest bets against them of any Russell 3000 stocks as of January 29. They're ranked from lowest to highest based on the short interest as a percentage of their overall share float.</p><p><strong>SEE ALSO: <a href="https://www.businessinsider.com/investing-strategy-for-market-crashes-risk-parity-etf-damien-bisserier-2021-2" >One of Wall Street's most popular self-defense strategies failed during the coronavirus meltdown. Ex-Bridgewater advisor Damien Bisserier was among the few who made it work, and he told us how he did it.</a></strong></p><h3>40. OPKO Health</h3><img src="https://static6.businessinsider.com/image/6026ab16b3c2a800183cc99b-400-300/40-opko-health.jpg" alt="" /><p><p><strong>Ticker</strong>: <a href="https://markets.businessinsider.com/stocks/opk-stock">OPK</a></p><p><strong>Sector</strong>: Healthcare</p><p><strong>Market cap</strong>: $3.8 billion</p><p><strong>Short interest as of January 29</strong>: 25%</p><p><em>Source: Goldman Sachs</em></p></p><br/><br/><h3>39. vTv Therapeutics</h3><img src="https://static3.businessinsider.com/image/6026ac7bb3c2a800183cc9af-400-300/39-vtv-therapeutics.jpg" alt="" /><p><p><strong>Ticker</strong>: <a href="https://markets.businessinsider.com/stocks/vtvt-stock">VTVT</a></p><p><strong>Sector</strong>: Healthcare</p><p><strong>Market cap</strong>: $130 million</p><p><strong>Short interest as of January 29</strong>: 25%</p><p><em>Source: Goldman Sachs</em></p></p><br/><br/><h3>38. B&G Foods</h3><img src="https://static2.businessinsider.com/image/6026ad302edd0f001a8d5876-400-300/38-bg-foods.jpg" alt="" /><p><p><strong>Ticker</strong>: <a href="https://markets.businessinsider.com/stocks/bgs-stock">BGS</a></p><p><strong>Sector</strong>: Consumer staples</p><p><strong>Market cap</strong>: $3.1 billion</p><p><strong>Short interest as of January 29</strong>: 25%</p><p><em>Source: Goldman Sachs</em></p></p><br/><br/><h3>37. BigCommerce Holdings</h3><img src="https://static2.businessinsider.com/image/6026ae8f2edd0f001a8d5881-400-300/37-bigcommerce-holdings.jpg" alt="" /><p><p><strong>Ticker</strong>: <a href="https://markets.businessinsider.com/stocks/bigc-stock">BIGC</a></p><p><strong>Sector</strong>: Information technology</p><p><strong>Market cap</strong>: $4.9 billion</p><p><strong>Short interest as of January 29</strong>: 26%</p><p><em>Source: Goldman Sachs</em></p><p> </p></p><br/><br/><h3>36. Alpha Pro Tech</h3><img src="https://static3.businessinsider.com/image/6026b1ee2edd0f001a8d589a-400-300/36-alpha-pro-tech.jpg" alt="" /><p><p><strong>Ticker</strong>: <a href="https://markets.businessinsider.com/stocks/apt-stock">APT</a></p><p><strong>Sector</strong>: Industrials</p><p><strong>Market cap</strong>: $257 million</p><p><strong>Short interest as of January 29</strong>: 26%</p><p><em>Source: Goldman Sachs</em></p></p><br/><br/><h3>35. Tabula Rasa Healthcare</h3><img src="https://static3.businessinsider.com/image/6026b26a2edd0f001a8d58a5-400-300/35-tabula-rasa-healthcare.jpg" alt="" /><p><p><strong>Ticker</strong>: <a href="https://markets.businessinsider.com/stocks/trhc-stock">TRHC</a></p><p><strong>Sector</strong>: Healthcare</p><p><strong>Market cap</strong>: $1.3 billion</p><p><strong>Short interest as of January 29</strong>: 26%</p><p><em>Source: Goldman Sachs</em></p></p><br/><br/><h3>34. Kaleido Biosciences</h3><img src="https://static1.businessinsider.com/image/6026b2b5b3c2a800183cc9e3-400-300/34-kaleido-biosciences.jpg" alt="" /><p><p><strong>Ticker</strong>: <a href="https://markets.businessinsider.com/stocks/kldo-stock">KLDO</a></p><p><strong>Sector</strong>: Healthcare</p><p><strong>Market cap</strong>: $454 million</p><p><strong>Short interest as of January 29</strong>: 26%</p><p><em>Source: Goldman Sachs</em></p></p><br/><br/><h3>33. TherapeuticsMD</h3><img src="https://static6.businessinsider.com/image/6026b353b3c2a800183cc9ed-400-300/33-therapeuticsmd.jpg" alt="" /><p><p><strong>Ticker</strong>: <a href="https://markets.businessinsider.com/stocks/txmd-stock">TXMD</a></p><p><strong>Sector</strong>: Healthcare</p><p><strong>Market cap</strong>: $650 million</p><p><strong>Short interest as of January 29</strong>: 26%</p><p><em>Source: Goldman Sachs</em></p></p><br/><br/><h3>32. Madrigal Pharmaceuticals</h3><img src="https://static4.businessinsider.com/image/6026b3932edd0f001a8d58b4-400-300/32-madrigal-pharmaceuticals.jpg" alt="" /><p><p><strong>Ticker</strong>: <a href="https://markets.businessinsider.com/stocks/mdgl-stock">MDGL</a></p><p><strong>Sector</strong>: Healthcare</p><p><strong>Market cap</strong>: $1.9 billion</p><p><strong>Short interest as of January 29</strong>: 26%</p><p><em>Source: Goldman Sachs</em></p></p><br/><br/><h3>31. Inovio Pharmaceuticals</h3><img src="https://static3.businessinsider.com/image/6026b3fcb3c2a800183cc9f1-400-300/31-inovio-pharmaceuticals.jpg" alt="" /><p><p><strong>Ticker</strong>: <a href="https://markets.businessinsider.com/stocks/ino-stock">INO</a></p><p><strong>Sector</strong>: Healthcare</p><p><strong>Market cap</strong>: $2.7 billion</p><p><strong>Short interest as of January 29</strong>: 26%</p><p><em>Source: Goldman Sachs</em></p></p><br/><br/><h3>30. Continental Resources</h3><img src="https://static5.businessinsider.com/image/6026b6592edd0f001a8d58ce-400-300/30-continental-resources.jpg" alt="" /><p><p><strong>Ticker</strong>: <a href="https://markets.businessinsider.com/stocks/clr-stock">CLR</a></p><p><strong>Sector</strong>: Energy</p><p><strong>Market cap</strong>: $8.4 billion</p><p><strong>Short interest as of January 29</strong>: 26%</p><p><em>Source: Goldman Sachs</em></p></p><br/><br/><h3>29. BioXcel Therapeutics</h3><img src="https://static3.businessinsider.com/image/6026b6b22edd0f001a8d58d1-400-300/29-bioxcel-therapeutics.jpg" alt="" /><p><p><strong>Ticker</strong>: <a href="https://markets.businessinsider.com/stocks/btai-stock">BTAI</a></p><p><strong>Sector</strong>: Healthcare</p><p><strong>Market cap</strong>: $1.5 billion</p><p><strong>Short interest as of January 29</strong>: 27%</p><p><em>Source: Goldman Sachs</em></p></p><br/><br/><h3>28. Bed Bath & Beyond</h3><img src="https://static4.businessinsider.com/image/6026b6eeb3c2a800183cca01-400-300/28-bed-bath-and-beyond.jpg" alt="" /><p><p><strong>Ticker</strong>: <a href="https://markets.businessinsider.com/stocks/bbby-stock">BBBY</a></p><p><strong>Sector</strong>: Consumer discretionary</p><p><strong>Market cap</strong>: $3.5 billion</p><p><strong>Short interest as of January 29</strong>: 27%</p><p><em>Source: Goldman Sachs</em></p></p><br/><br/><h3>27. PetMed Express</h3><img src="https://static2.businessinsider.com/image/6026b727b3c2a800183cca03-400-300/27-petmed-express.jpg" alt="" /><p><p><strong>Ticker</strong>: <a href="https://markets.businessinsider.com/stocks/pets-stock">PETS</a></p><p><strong>Sector</strong>: Consumer discretionary</p><p><strong>Market cap</strong>: $708 million</p><p><strong>Short interest as of January 29</strong>: 27%</p><p><em>Source: Goldman Sachs</em></p></p><br/><br/><h3>26. Buckle</h3><img src="https://static4.businessinsider.com/image/6026b7582edd0f001a8d58da-400-300/26-buckle.jpg" alt="" /><p><p><strong>Ticker</strong>: <a href="https://markets.businessinsider.com/stocks/bke-stock">BKE</a></p><p><strong>Sector</strong>: Consumer discretionary</p><p><strong>Market cap</strong>: $2.0 billion</p><p><strong>Short interest as of January 29</strong>: 27%</p><p><em>Source: Goldman Sachs</em></p></p><br/><br/><h3>25. Revlon</h3><img src="https://static1.businessinsider.com/image/6026b79db3c2a800183cca0a-400-300/25-revlon.jpg" alt="" /><p><p><strong>Ticker</strong>: <a href="https://markets.businessinsider.com/stocks/rev-stock">REV</a></p><p><strong>Sector</strong>: Consumer staples</p><p><strong>Market cap</strong>: $595 million</p><p><strong>Short interest as of January 29</strong>: 28%</p><p><em>Source: Goldman Sachs</em></p></p><br/><br/><h3>24. Vaxart</h3><img src="https://static4.businessinsider.com/image/6026b7e22edd0f001a8d58e3-400-300/24-vaxart.jpg" alt="" /><p><p><strong>Ticker</strong>: <a href="https://markets.businessinsider.com/stocks/vxrt-stock">VXRT</a></p><p><strong>Sector</strong>: Healthcare</p><p><strong>Market cap</strong>: $922 million</p><p><strong>Short interest as of January 29</strong>: 28%</p><p><em>Source: Goldman Sachs</em></p></p><br/><br/><h3>23. Seritage Growth Properties</h3><img src="https://static4.businessinsider.com/image/6026b8182edd0f001a8d58e8-400-300/23-seritage-growth-properties.jpg" alt="" /><p><p><strong>Ticker</strong>: <a href="https://markets.businessinsider.com/stocks/srg-stock">SRG</a></p><p><strong>Sector</strong>: Real estate</p><p><strong>Market cap</strong>: $759 million</p><p><strong>Short interest as of January 29</strong>: 28%</p><p><em>Source: Goldman Sachs</em></p></p><br/><br/><h3>22. Intercept Pharmaceuticals</h3><img src="https://static4.businessinsider.com/image/6026b850b3c2a800183cca13-400-300/22-intercept-pharmaceuticals.jpg" alt="" /><p><p><strong>Ticker</strong>: <a href="https://markets.businessinsider.com/stocks/icpt-stock">ICPT</a></p><p><strong>Sector</strong>: Healthcare</p><p><strong>Market cap</strong>: $1.1 billion</p><p><strong>Short interest as of January 29</strong>: 28%</p><p><em>Source: Goldman Sachs</em></p></p><br/><br/><h3>21. Fulgent Genetics</h3><img src="https://static4.businessinsider.com/image/6026b896b3c2a800183cca17-400-300/21-fulgent-genetics.jpg" alt="" /><p><p><strong>Ticker</strong>: <a href="https://markets.businessinsider.com/stocks/flgt-stock">FLGT</a></p><p><strong>Sector</strong>: Healthcare</p><p><strong>Market cap</strong>: $4.2 billion</p><p><strong>Short interest as of January 29</strong>: 30%</p><p><em>Source: Goldman Sachs</em></p></p><br/><br/><h3>20. Retractable Technologies</h3><img src="https://static4.businessinsider.com/image/6026b9a3b3c2a800183cca27-400-300/20-retractable-technologies.jpg" alt="" /><p><p><strong>Ticker</strong>: <a href="https://markets.businessinsider.com/stocks/rvp-stock">RVP</a></p><p><strong>Sector</strong>: Healthcare</p><p><strong>Market cap</strong>: $583 million</p><p><strong>Short interest as of January 29</strong>: 30%</p><p><em>Source: Goldman Sachs</em></p></p><br/><br/><h3>19. Tootsie Roll Industries</h3><img src="https://static2.businessinsider.com/image/6026b9d7b3c2a800183cca29-400-300/19-tootsie-roll-industries.jpg" alt="" /><p><p><strong>Ticker</strong>: <a href="https://markets.businessinsider.com/stocks/tr-stock">TR</a></p><p><strong>Sector</strong>: Consumer staples</p><p><strong>Market cap</strong>: $2.1 billion</p><p><strong>Short interest as of January 29</strong>: 31%</p><p><em>Source: Goldman Sachs</em></p></p><br/><br/><h3>18. Discovery</h3><img src="https://static3.businessinsider.com/image/6026ba0eb3c2a800183cca2c-400-300/18-discovery.jpg" alt="" /><p><p><strong>Ticker</strong>: <a href="https://markets.businessinsider.com/stocks/disca-stock">DISCA</a></p><p><strong>Sector</strong>: Communication services</p><p><strong>Market cap</strong>: $22.9 billion</p><p><strong>Short interest as of January 29</strong>: 31%</p><p><em>Source: Goldman Sachs</em></p></p><br/><br/><h3>17. Zynex</h3><img src="https://static2.businessinsider.com/image/6026ba462edd0f001a8d5901-400-300/17-zynex.jpg" alt="" /><p><p><strong>Ticker</strong>: <a href="https://markets.businessinsider.com/stocks/zyxi-stock">ZYXI</a></p><p><strong>Sector</strong>: Healthcare</p><p><strong>Market cap</strong>: $677 million</p><p><strong>Short interest as of January 29</strong>: 31%</p><p><em>Source: Goldman Sachs</em></p></p><br/><br/><h3>16. Rocket Companies</h3><img src="https://static2.businessinsider.com/image/6026babd2edd0f001a8d5909-400-300/16-rocket-companies.jpg" alt="" /><p><p><strong>Ticker</strong>: <a href="https://markets.businessinsider.com/stocks/rkt-stock">RKT</a></p><p><strong>Sector</strong>: Financials</p><p><strong>Market cap</strong>: $40.8 billion</p><p><strong>Short interest as of January 29</strong>: 31%</p><p><em>Source: Goldman Sachs</em></p></p><br/><br/><h3>15. Ontrak</h3><img src="https://static2.businessinsider.com/image/6026bc952edd0f001a8d5915-400-300/15-ontrak.jpg" alt="" /><p><p><strong>Ticker</strong>: <a href="https://markets.businessinsider.com/stocks/otrk-stock">OTRK</a></p><p><strong>Sector</strong>: Healthcare</p><p><strong>Market cap</strong>: $1.6 billion</p><p><strong>Short interest as of January 29</strong>: 32%</p><p><em>Source: Goldman Sachs</em></p></p><br/><br/><h3>14. SunPower</h3><img src="https://static1.businessinsider.com/image/6026bcd2b3c2a800183cca44-400-300/14-sunpower.jpg" alt="" /><p><p><strong>Ticker</strong>: <a href="https://markets.businessinsider.com/stocks/spwr-stock">SPWR</a></p><p><strong>Sector</strong>: Information technology</p><p><strong>Market cap</strong>: $8.4 billion</p><p><strong>Short interest as of January 29</strong>: 32%</p><p><em>Source: Goldman Sachs</em></p></p><br/><br/><h3>13. Marcus</h3><img src="https://static1.businessinsider.com/image/6026bd062edd0f001a8d591a-400-300/13-marcus.jpg" alt="" /><p><p><strong>Ticker</strong>: <a href="https://markets.businessinsider.com/stocks/mcs-stock">MCS</a></p><p><strong>Sector</strong>: Communication services</p><p><strong>Market cap</strong>: $532 million</p><p><strong>Short interest as of January 29</strong>: 32%</p><p><em>Source: Goldman Sachs</em></p></p><br/><br/><h3>12. AMC Networks</h3><img src="https://static4.businessinsider.com/image/6026bd502edd0f001a8d591c-400-300/12-amc-networks.jpg" alt="" /><p><p><strong>Ticker</strong>: <a href="https://markets.businessinsider.com/stocks/amcx-stock">AMCX</a></p><p><strong>Sector</strong>: Communication services</p><p><strong>Market cap</strong>: $2.0 billion</p><p><strong>Short interest as of January 29</strong>: 33%</p><p><em>Source: Goldman Sachs</em></p></p><br/><br/><h3>11. Precigen</h3><img src="https://static6.businessinsider.com/image/6026bd872edd0f001a8d591f-400-300/11-precigen.jpg" alt="" /><p><p><strong>Ticker</strong>: <a href="https://markets.businessinsider.com/stocks/pgen-stock">PGEN</a></p><p><strong>Sector</strong>: Healthcare</p><p><strong>Market cap</strong>: $1.8 billion</p><p><strong>Short interest as of January 29</strong>: 33%</p><p><em>Source: Goldman Sachs</em></p></p><br/><br/><h3>10. National Beverage</h3><img src="https://static5.businessinsider.com/image/6026bdbd2edd0f001a8d5923-400-300/10-national-beverage.jpg" alt="" /><p><p><strong>Ticker</strong>: <a href="https://markets.businessinsider.com/stocks/fizz-stock">FIZZ</a></p><p><strong>Sector</strong>: Consumer staples</p><p><strong>Market cap</strong>: $5.5 billion</p><p><strong>Short interest as of January 29</strong>: 35%</p><p><em>Source: Goldman Sachs</em></p></p><br/><br/><h3>9. Accelerate Diagnostics</h3><img src="https://static1.businessinsider.com/image/6026be39b3c2a800183cca54-400-300/9-accelerate-diagnostics.jpg" alt="" /><p><p><strong>Ticker</strong>: <a href="https://markets.businessinsider.com/stocks/axdx-stock">AXDX</a></p><p><strong>Sector</strong>: Healthcare</p><p><strong>Market cap</strong>: $750 million</p><p><strong>Short interest as of January 29</strong>: 36%</p><p><em>Source: Goldman Sachs</em></p></p><br/><br/><h3>8. Esperion Therapeutics</h3><img src="https://static2.businessinsider.com/image/6026be71b3c2a800183cca55-400-300/8-esperion-therapeutics.jpg" alt="" /><p><p><strong>Ticker</strong>: <a href="https://markets.businessinsider.com/stocks/espr-stock">ESPR</a></p><p><strong>Sector</strong>: Healthcare</p><p><strong>Market cap</strong>: $896 million</p><p><strong>Short interest as of January 29</strong>: 38%</p><p><em>Source: Goldman Sachs</em></p><p> </p></p><br/><br/><h3>7. Ligand Pharmaceuticals</h3><img src="https://static3.businessinsider.com/image/6026beb72edd0f001a8d592d-400-300/7-ligand-pharmaceuticals.jpg" alt="" /><p><p><strong>Ticker</strong>: <a href="https://markets.businessinsider.com/stocks/lgnd-stock">LGND</a></p><p><strong>Sector</strong>: Healthcare</p><p><strong>Market cap</strong>: $3.4 billion</p><p><strong>Short interest as of January 29</strong>: 39%</p><p><em>Source: Goldman Sachs</em></p></p><br/><br/><h3>6. Tanger Factory Outlet Centers</h3><img src="https://static3.businessinsider.com/image/6026bf562edd0f001a8d5936-400-300/6-tanger-factory-outlet-centers.jpg" alt="" /><p><p><strong>Ticker</strong>: <a href="https://markets.businessinsider.com/stocks/skt-stock">SKT</a></p><p><strong>Sector</strong>: Real estate</p><p><strong>Market cap</strong>: $1.4 billion</p><p><strong>Short interest as of January 29</strong>: 41%</p><p><em>Source: Goldman Sachs</em></p></p><br/><br/><h3>5. International Flavors & Fragrances</h3><img src="https://static2.businessinsider.com/image/6026bf98b3c2a800183cca63-400-300/5-international-flavors-and-fragrances.jpg" alt="" /><p><p><strong>Ticker</strong>: <a href="https://markets.businessinsider.com/stocks/iff-stock">IFF</a></p><p><strong>Sector</strong>: Materials</p><p><strong>Market cap</strong>: $33.7 billion</p><p><strong>Short interest as of January 29</strong>: 41%</p><p><em>Source: Goldman Sachs</em></p></p><br/><br/><h3>4. Clovis Oncology</h3><img src="https://static1.businessinsider.com/image/6026bfd2b3c2a800183cca64-400-300/4-clovis-oncology.jpg" alt="" /><p><p><strong>Ticker</strong>: <a href="https://markets.businessinsider.com/stocks/clvs-stock">CLVS</a></p><p><strong>Sector</strong>: Healthcare</p><p><strong>Market cap</strong>: $842 million</p><p><strong>Short interest as of January 29</strong>: 42%</p><p><em>Source: Goldman Sachs</em></p></p><br/><br/><h3>3. GameStop</h3><img src="https://static6.businessinsider.com/image/6026c00e2edd0f001a8d593a-400-300/3-gamestop.jpg" alt="" /><p><p><strong>Ticker</strong>: <a href="https://markets.businessinsider.com/stocks/gme-stock">GME</a></p><p><strong>Sector</strong>: Consumer discretionary</p><p><strong>Market cap</strong>: $3.6 billion</p><p><strong>Short interest as of January 29</strong>: 43%</p><p><em>Source: Goldman Sachs</em></p></p><br/><br/><h3>2. Gogo</h3><img src="https://static3.businessinsider.com/image/6026c0632edd0f001a8d593b-400-300/2-gogo.jpg" alt="" /><p><p><strong>Ticker</strong>: <a href="https://markets.businessinsider.com/stocks/gogo-stock">GOGO</a></p><p><strong>Sector</strong>: Communication services</p><p><strong>Market cap</strong>: $1.2 billion</p><p><strong>Short interest as of January 29</strong>: 43%</p><p><em>Source: Goldman Sachs</em></p></p><br/><br/><h3>1. Academy Sports and Outdoors</h3><img src="https://static6.businessinsider.com/image/6026c0abb3c2a800183cca66-400-300/1-academy-sports-and-outdoors.jpg" alt="" /><p><p><strong>Ticker</strong>: <a href="https://markets.businessinsider.com/stocks/aso-stock">ASO</a></p><p><strong>Sector</strong>: Consumer discretionary</p><p><strong>Market cap</strong>: $2.3 billion</p><p><strong>Short interest as of January 29</strong>: 46%</p><p><em>Source: Goldman Sachs</em></p></p><br/><br/>
Click here to read full news..
